Loading…
Reduction Effect of Calcium Alginate on Blood Triglyceride Levels Causing the Inhibition of Hepatic and Total Body Accumulation of Fat in Rats
In this study, rats were fed a high-fat diet containing calcium alginate (Ca-Alg) for 5 weeks to examine the effects of Ca-Alg on lipid metabolism including triglyceride (TG) levels in the blood. We also investigated the mechanism of the TG-reducing effect of Alg in vitro. Rats were randomized into...
Saved in:
Published in: | Biological & pharmaceutical bulletin 2019/03/01, Vol.42(3), pp.365-372 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c658t-4f51c00102adc270460a9f9fd732f1b8fa1139dbb4dc7afb705d077cebc20a13 |
---|---|
cites | cdi_FETCH-LOGICAL-c658t-4f51c00102adc270460a9f9fd732f1b8fa1139dbb4dc7afb705d077cebc20a13 |
container_end_page | 372 |
container_issue | 3 |
container_start_page | 365 |
container_title | Biological & pharmaceutical bulletin |
container_volume | 42 |
creator | Kasahara, Fumiyoshi Kato, Takako Idota, Yoko Takahashi, Hitoe Kakinuma, Chihaya Yano, Kentaro Arakawa, Hiroshi Hara, Kurt Miyajima, Chihiro Ogihara, Takuo |
description | In this study, rats were fed a high-fat diet containing calcium alginate (Ca-Alg) for 5 weeks to examine the effects of Ca-Alg on lipid metabolism including triglyceride (TG) levels in the blood. We also investigated the mechanism of the TG-reducing effect of Alg in vitro. Rats were randomized into 5 groups: high-fat diet group (14% (w/w) lard, HF); three Ca-Alg-containing diet groups (2.5, 5 or 10% (w/w) Ca-Alg) and a resistant maltodextrin (RMD) diet group as a positive control (with 5% (w/w) RMD). The 10% Ca-Alg group showed a significant reduction of body weight increase from the 7th day. In addition, the increase of TG in blood was significantly suppressed, and the amount of TG excreted in feces was increased. Increase of body fat mass was in the order HF > RMD > Ca-Alg 2.5% > Ca-Alg 5% > Ca-Alg 10%, while the total weight of the extracted fat tissues was significantly reduced in the RMD, 5% and 10% Ca-Alg groups. Hepatic pathology showed clear circular vacuoles apparently representing TG accumulation in the HF group, while fewer vacuoles were seen in the Ca-Alg groups. The results of in vitro experiments indicated that Ca-Alg does not directly inhibit lipase activity, but may suppress absorption of TG by forming non-absorbable macromolecular micelles containing TG. These results suggest that Ca-Alg promotes excretion and suppresses absorption of TG, leading to reduced blood TG levels, and decreased hepatic and total body accumulation of fat. The findings should be helpful for designing future clinical trials. |
doi_str_mv | 10.1248/bpb.b18-00530 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2187956201</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2187956201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c658t-4f51c00102adc270460a9f9fd732f1b8fa1139dbb4dc7afb705d077cebc20a13</originalsourceid><addsrcrecordid>eNpdkV-LGyEUxaW0dLdpH_tahL70ZbZXnRlnHrNh_0GgsORd1NHEYDQdnUK-xH7mmmQ3hYJcH87vnnvgIPSVwA2hdfdT7dWNIl0F0DB4h64Jq3nVUNK8R9fQF6ElTXeFPqW0BQAOlH1EVww62kHbX6OXZzNMOrsY8J21RmccLV5Ir920w3O_dkFmg4t662Mc8Gp0a3_QZnSDwUvzx_hU6Cm5sMZ5Y_BT2DjlTnbF59HsZXYay1A2Y5Ye38bhgOdaT7vJyzfsXmbsAn6WOX1GH6z0yXx5_WdodX-3WjxWy18PT4v5stJt0-Wqtg3RAASoHDTlULcge9vbgTNqieqsJIT1g1L1oLm0ikMzAOfaKE1BEjZDP862-zH-nkzKYueSNt7LYOKUBCUd75uWwhH9_h-6jdMYSjhBaU0YheOboepM6TGmNBor9qPbyfEgCIhjT6L0JEpP4tRT4b-9uk5qZ4YL_VZMAR7OQFGdlj4G74L5d1snrlz0UZSMfTGtSwgBhAhgbVMGp4yy5nhshhZnp23Kcm0up-RYqvHmFKymgh3HJeBF1Rs5ChPYX4i6vLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2241320320</pqid></control><display><type>article</type><title>Reduction Effect of Calcium Alginate on Blood Triglyceride Levels Causing the Inhibition of Hepatic and Total Body Accumulation of Fat in Rats</title><source>Full-Text Journals in Chemistry (Open access)</source><creator>Kasahara, Fumiyoshi ; Kato, Takako ; Idota, Yoko ; Takahashi, Hitoe ; Kakinuma, Chihaya ; Yano, Kentaro ; Arakawa, Hiroshi ; Hara, Kurt ; Miyajima, Chihiro ; Ogihara, Takuo</creator><creatorcontrib>Kasahara, Fumiyoshi ; Kato, Takako ; Idota, Yoko ; Takahashi, Hitoe ; Kakinuma, Chihaya ; Yano, Kentaro ; Arakawa, Hiroshi ; Hara, Kurt ; Miyajima, Chihiro ; Ogihara, Takuo ; Institute of Medical ; Kanazawa University ; Takasaki University of Health and Welfare ; cKendai Translational Research Center ; Pharmaceutical and Health Sciences ; Graduate School of Pharmaceutical Sciences ; eLaboratory of Clinical Pharmacokinetics ; aFaculty of Pharmacy ; dFaculty of Pharmacy ; bKimica Corporation</creatorcontrib><description>In this study, rats were fed a high-fat diet containing calcium alginate (Ca-Alg) for 5 weeks to examine the effects of Ca-Alg on lipid metabolism including triglyceride (TG) levels in the blood. We also investigated the mechanism of the TG-reducing effect of Alg in vitro. Rats were randomized into 5 groups: high-fat diet group (14% (w/w) lard, HF); three Ca-Alg-containing diet groups (2.5, 5 or 10% (w/w) Ca-Alg) and a resistant maltodextrin (RMD) diet group as a positive control (with 5% (w/w) RMD). The 10% Ca-Alg group showed a significant reduction of body weight increase from the 7th day. In addition, the increase of TG in blood was significantly suppressed, and the amount of TG excreted in feces was increased. Increase of body fat mass was in the order HF > RMD > Ca-Alg 2.5% > Ca-Alg 5% > Ca-Alg 10%, while the total weight of the extracted fat tissues was significantly reduced in the RMD, 5% and 10% Ca-Alg groups. Hepatic pathology showed clear circular vacuoles apparently representing TG accumulation in the HF group, while fewer vacuoles were seen in the Ca-Alg groups. The results of in vitro experiments indicated that Ca-Alg does not directly inhibit lipase activity, but may suppress absorption of TG by forming non-absorbable macromolecular micelles containing TG. These results suggest that Ca-Alg promotes excretion and suppresses absorption of TG, leading to reduced blood TG levels, and decreased hepatic and total body accumulation of fat. The findings should be helpful for designing future clinical trials.</description><identifier>ISSN: 0918-6158</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.b18-00530</identifier><identifier>PMID: 30828069</identifier><language>eng</language><publisher>Japan: The Pharmaceutical Society of Japan</publisher><subject>Absorption ; Accumulation ; Alginic acid ; Blood levels ; Body fat ; Body weight ; Calcium ; Calcium (blood) ; Calcium alginate ; Clinical trials ; Excretion ; fat ; High fat diet ; Lipase ; lipid ; Lipid metabolism ; Liver ; Macromolecules ; Maltodextrin ; micelle ; Micelles ; Rodents ; triglyceride ; Vacuoles</subject><ispartof>Biological and Pharmaceutical Bulletin, 2019/03/01, Vol.42(3), pp.365-372</ispartof><rights>2019 The Pharmaceutical Society of Japan</rights><rights>Copyright Japan Science and Technology Agency 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c658t-4f51c00102adc270460a9f9fd732f1b8fa1139dbb4dc7afb705d077cebc20a13</citedby><cites>FETCH-LOGICAL-c658t-4f51c00102adc270460a9f9fd732f1b8fa1139dbb4dc7afb705d077cebc20a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30828069$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kasahara, Fumiyoshi</creatorcontrib><creatorcontrib>Kato, Takako</creatorcontrib><creatorcontrib>Idota, Yoko</creatorcontrib><creatorcontrib>Takahashi, Hitoe</creatorcontrib><creatorcontrib>Kakinuma, Chihaya</creatorcontrib><creatorcontrib>Yano, Kentaro</creatorcontrib><creatorcontrib>Arakawa, Hiroshi</creatorcontrib><creatorcontrib>Hara, Kurt</creatorcontrib><creatorcontrib>Miyajima, Chihiro</creatorcontrib><creatorcontrib>Ogihara, Takuo</creatorcontrib><creatorcontrib>Institute of Medical</creatorcontrib><creatorcontrib>Kanazawa University</creatorcontrib><creatorcontrib>Takasaki University of Health and Welfare</creatorcontrib><creatorcontrib>cKendai Translational Research Center</creatorcontrib><creatorcontrib>Pharmaceutical and Health Sciences</creatorcontrib><creatorcontrib>Graduate School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>eLaboratory of Clinical Pharmacokinetics</creatorcontrib><creatorcontrib>aFaculty of Pharmacy</creatorcontrib><creatorcontrib>dFaculty of Pharmacy</creatorcontrib><creatorcontrib>bKimica Corporation</creatorcontrib><title>Reduction Effect of Calcium Alginate on Blood Triglyceride Levels Causing the Inhibition of Hepatic and Total Body Accumulation of Fat in Rats</title><title>Biological & pharmaceutical bulletin</title><addtitle>Biol Pharm Bull</addtitle><description>In this study, rats were fed a high-fat diet containing calcium alginate (Ca-Alg) for 5 weeks to examine the effects of Ca-Alg on lipid metabolism including triglyceride (TG) levels in the blood. We also investigated the mechanism of the TG-reducing effect of Alg in vitro. Rats were randomized into 5 groups: high-fat diet group (14% (w/w) lard, HF); three Ca-Alg-containing diet groups (2.5, 5 or 10% (w/w) Ca-Alg) and a resistant maltodextrin (RMD) diet group as a positive control (with 5% (w/w) RMD). The 10% Ca-Alg group showed a significant reduction of body weight increase from the 7th day. In addition, the increase of TG in blood was significantly suppressed, and the amount of TG excreted in feces was increased. Increase of body fat mass was in the order HF > RMD > Ca-Alg 2.5% > Ca-Alg 5% > Ca-Alg 10%, while the total weight of the extracted fat tissues was significantly reduced in the RMD, 5% and 10% Ca-Alg groups. Hepatic pathology showed clear circular vacuoles apparently representing TG accumulation in the HF group, while fewer vacuoles were seen in the Ca-Alg groups. The results of in vitro experiments indicated that Ca-Alg does not directly inhibit lipase activity, but may suppress absorption of TG by forming non-absorbable macromolecular micelles containing TG. These results suggest that Ca-Alg promotes excretion and suppresses absorption of TG, leading to reduced blood TG levels, and decreased hepatic and total body accumulation of fat. The findings should be helpful for designing future clinical trials.</description><subject>Absorption</subject><subject>Accumulation</subject><subject>Alginic acid</subject><subject>Blood levels</subject><subject>Body fat</subject><subject>Body weight</subject><subject>Calcium</subject><subject>Calcium (blood)</subject><subject>Calcium alginate</subject><subject>Clinical trials</subject><subject>Excretion</subject><subject>fat</subject><subject>High fat diet</subject><subject>Lipase</subject><subject>lipid</subject><subject>Lipid metabolism</subject><subject>Liver</subject><subject>Macromolecules</subject><subject>Maltodextrin</subject><subject>micelle</subject><subject>Micelles</subject><subject>Rodents</subject><subject>triglyceride</subject><subject>Vacuoles</subject><issn>0918-6158</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpdkV-LGyEUxaW0dLdpH_tahL70ZbZXnRlnHrNh_0GgsORd1NHEYDQdnUK-xH7mmmQ3hYJcH87vnnvgIPSVwA2hdfdT7dWNIl0F0DB4h64Jq3nVUNK8R9fQF6ElTXeFPqW0BQAOlH1EVww62kHbX6OXZzNMOrsY8J21RmccLV5Ir920w3O_dkFmg4t662Mc8Gp0a3_QZnSDwUvzx_hU6Cm5sMZ5Y_BT2DjlTnbF59HsZXYay1A2Y5Ye38bhgOdaT7vJyzfsXmbsAn6WOX1GH6z0yXx5_WdodX-3WjxWy18PT4v5stJt0-Wqtg3RAASoHDTlULcge9vbgTNqieqsJIT1g1L1oLm0ikMzAOfaKE1BEjZDP862-zH-nkzKYueSNt7LYOKUBCUd75uWwhH9_h-6jdMYSjhBaU0YheOboepM6TGmNBor9qPbyfEgCIhjT6L0JEpP4tRT4b-9uk5qZ4YL_VZMAR7OQFGdlj4G74L5d1snrlz0UZSMfTGtSwgBhAhgbVMGp4yy5nhshhZnp23Kcm0up-RYqvHmFKymgh3HJeBF1Rs5ChPYX4i6vLQ</recordid><startdate>20190301</startdate><enddate>20190301</enddate><creator>Kasahara, Fumiyoshi</creator><creator>Kato, Takako</creator><creator>Idota, Yoko</creator><creator>Takahashi, Hitoe</creator><creator>Kakinuma, Chihaya</creator><creator>Yano, Kentaro</creator><creator>Arakawa, Hiroshi</creator><creator>Hara, Kurt</creator><creator>Miyajima, Chihiro</creator><creator>Ogihara, Takuo</creator><general>The Pharmaceutical Society of Japan</general><general>Pharmaceutical Society of Japan</general><general>Japan Science and Technology Agency</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20190301</creationdate><title>Reduction Effect of Calcium Alginate on Blood Triglyceride Levels Causing the Inhibition of Hepatic and Total Body Accumulation of Fat in Rats</title><author>Kasahara, Fumiyoshi ; Kato, Takako ; Idota, Yoko ; Takahashi, Hitoe ; Kakinuma, Chihaya ; Yano, Kentaro ; Arakawa, Hiroshi ; Hara, Kurt ; Miyajima, Chihiro ; Ogihara, Takuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c658t-4f51c00102adc270460a9f9fd732f1b8fa1139dbb4dc7afb705d077cebc20a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Absorption</topic><topic>Accumulation</topic><topic>Alginic acid</topic><topic>Blood levels</topic><topic>Body fat</topic><topic>Body weight</topic><topic>Calcium</topic><topic>Calcium (blood)</topic><topic>Calcium alginate</topic><topic>Clinical trials</topic><topic>Excretion</topic><topic>fat</topic><topic>High fat diet</topic><topic>Lipase</topic><topic>lipid</topic><topic>Lipid metabolism</topic><topic>Liver</topic><topic>Macromolecules</topic><topic>Maltodextrin</topic><topic>micelle</topic><topic>Micelles</topic><topic>Rodents</topic><topic>triglyceride</topic><topic>Vacuoles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kasahara, Fumiyoshi</creatorcontrib><creatorcontrib>Kato, Takako</creatorcontrib><creatorcontrib>Idota, Yoko</creatorcontrib><creatorcontrib>Takahashi, Hitoe</creatorcontrib><creatorcontrib>Kakinuma, Chihaya</creatorcontrib><creatorcontrib>Yano, Kentaro</creatorcontrib><creatorcontrib>Arakawa, Hiroshi</creatorcontrib><creatorcontrib>Hara, Kurt</creatorcontrib><creatorcontrib>Miyajima, Chihiro</creatorcontrib><creatorcontrib>Ogihara, Takuo</creatorcontrib><creatorcontrib>Institute of Medical</creatorcontrib><creatorcontrib>Kanazawa University</creatorcontrib><creatorcontrib>Takasaki University of Health and Welfare</creatorcontrib><creatorcontrib>cKendai Translational Research Center</creatorcontrib><creatorcontrib>Pharmaceutical and Health Sciences</creatorcontrib><creatorcontrib>Graduate School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>eLaboratory of Clinical Pharmacokinetics</creatorcontrib><creatorcontrib>aFaculty of Pharmacy</creatorcontrib><creatorcontrib>dFaculty of Pharmacy</creatorcontrib><creatorcontrib>bKimica Corporation</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biological & pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kasahara, Fumiyoshi</au><au>Kato, Takako</au><au>Idota, Yoko</au><au>Takahashi, Hitoe</au><au>Kakinuma, Chihaya</au><au>Yano, Kentaro</au><au>Arakawa, Hiroshi</au><au>Hara, Kurt</au><au>Miyajima, Chihiro</au><au>Ogihara, Takuo</au><aucorp>Institute of Medical</aucorp><aucorp>Kanazawa University</aucorp><aucorp>Takasaki University of Health and Welfare</aucorp><aucorp>cKendai Translational Research Center</aucorp><aucorp>Pharmaceutical and Health Sciences</aucorp><aucorp>Graduate School of Pharmaceutical Sciences</aucorp><aucorp>eLaboratory of Clinical Pharmacokinetics</aucorp><aucorp>aFaculty of Pharmacy</aucorp><aucorp>dFaculty of Pharmacy</aucorp><aucorp>bKimica Corporation</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduction Effect of Calcium Alginate on Blood Triglyceride Levels Causing the Inhibition of Hepatic and Total Body Accumulation of Fat in Rats</atitle><jtitle>Biological & pharmaceutical bulletin</jtitle><addtitle>Biol Pharm Bull</addtitle><date>2019-03-01</date><risdate>2019</risdate><volume>42</volume><issue>3</issue><spage>365</spage><epage>372</epage><pages>365-372</pages><issn>0918-6158</issn><eissn>1347-5215</eissn><abstract>In this study, rats were fed a high-fat diet containing calcium alginate (Ca-Alg) for 5 weeks to examine the effects of Ca-Alg on lipid metabolism including triglyceride (TG) levels in the blood. We also investigated the mechanism of the TG-reducing effect of Alg in vitro. Rats were randomized into 5 groups: high-fat diet group (14% (w/w) lard, HF); three Ca-Alg-containing diet groups (2.5, 5 or 10% (w/w) Ca-Alg) and a resistant maltodextrin (RMD) diet group as a positive control (with 5% (w/w) RMD). The 10% Ca-Alg group showed a significant reduction of body weight increase from the 7th day. In addition, the increase of TG in blood was significantly suppressed, and the amount of TG excreted in feces was increased. Increase of body fat mass was in the order HF > RMD > Ca-Alg 2.5% > Ca-Alg 5% > Ca-Alg 10%, while the total weight of the extracted fat tissues was significantly reduced in the RMD, 5% and 10% Ca-Alg groups. Hepatic pathology showed clear circular vacuoles apparently representing TG accumulation in the HF group, while fewer vacuoles were seen in the Ca-Alg groups. The results of in vitro experiments indicated that Ca-Alg does not directly inhibit lipase activity, but may suppress absorption of TG by forming non-absorbable macromolecular micelles containing TG. These results suggest that Ca-Alg promotes excretion and suppresses absorption of TG, leading to reduced blood TG levels, and decreased hepatic and total body accumulation of fat. The findings should be helpful for designing future clinical trials.</abstract><cop>Japan</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>30828069</pmid><doi>10.1248/bpb.b18-00530</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0918-6158 |
ispartof | Biological and Pharmaceutical Bulletin, 2019/03/01, Vol.42(3), pp.365-372 |
issn | 0918-6158 1347-5215 |
language | eng |
recordid | cdi_proquest_miscellaneous_2187956201 |
source | Full-Text Journals in Chemistry (Open access) |
subjects | Absorption Accumulation Alginic acid Blood levels Body fat Body weight Calcium Calcium (blood) Calcium alginate Clinical trials Excretion fat High fat diet Lipase lipid Lipid metabolism Liver Macromolecules Maltodextrin micelle Micelles Rodents triglyceride Vacuoles |
title | Reduction Effect of Calcium Alginate on Blood Triglyceride Levels Causing the Inhibition of Hepatic and Total Body Accumulation of Fat in Rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T23%3A46%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduction%20Effect%20of%20Calcium%20Alginate%20on%20Blood%20Triglyceride%20Levels%20Causing%20the%20Inhibition%20of%20Hepatic%20and%20Total%20Body%20Accumulation%20of%20Fat%20in%20Rats&rft.jtitle=Biological%20&%20pharmaceutical%20bulletin&rft.au=Kasahara,%20Fumiyoshi&rft.aucorp=Institute%20of%20Medical&rft.date=2019-03-01&rft.volume=42&rft.issue=3&rft.spage=365&rft.epage=372&rft.pages=365-372&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.b18-00530&rft_dat=%3Cproquest_cross%3E2187956201%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c658t-4f51c00102adc270460a9f9fd732f1b8fa1139dbb4dc7afb705d077cebc20a13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2241320320&rft_id=info:pmid/30828069&rfr_iscdi=true |